Covered recipient · General Payments record
RACHAEL L JOHNSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,556.03
- Reported across 88 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $422.60 | 15 |
| Education | $13.35 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $233.74 | 6 |
| Exeltis, USA Inc. | $79.24 | 4 |
| ABBVIE INC. | $38.88 | 2 |
| BAXTER HEALTHCARE | $32.10 | 1 |
| Sumitomo Pharma America, Inc. | $24.69 | 1 |
| Biogen, Inc. | $13.95 | 1 |
| MILLICENT US INC | $13.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.67 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107413066 | CMS |
| ABBVIE INC. | $15.21 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107413068 | CMS |
| Astellas Pharma US Inc | $28.98 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139468142 | CMS |
| Astellas Pharma US Inc | $20.68 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139476666 | CMS |
| Astellas Pharma US Inc | $18.08 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139465030 | CMS |
| Astellas Pharma US Inc | $125.00 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139523186 | CMS |
| Astellas Pharma US Inc | $19.40 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139493604 | CMS |
| Astellas Pharma US Inc | $21.60 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139508287 | CMS |
| Baxter Healthcare | $32.10 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120534837 | CMS |
| Biogen, Inc. | $13.95 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104822634 | CMS |
| Exeltis, USA Inc. | $22.15 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150014301 | CMS |
| Exeltis, USA Inc. | $19.11 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150014303 | CMS |
| Exeltis, USA Inc. | $22.26 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150014305 | CMS |
| Exeltis, USA Inc. | $15.72 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150014307 | CMS |
| MILLICENT US INC | $13.35 | 10/18/2024 | Education | Undisputed | 01/23/2026 | 1150915380 | CMS |
| Sumitomo Pharma America, Inc. | $24.69 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148970199 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.